Tamara van Donge

Chapter 7 142 References 1. Ceriotti F. Establishing Pediatric Reference Intervals: A Challenging Task. Clinical Chemistry. 2012;58(5):808-810. 2. Colantonio DA, Kyriakopoulou L, Chan MK, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clinical chemistry. 2012;58(5):854-868. 3. George I, Mekahli D, Rayyan M, Levtchenko E, Allegaert K. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatric nephrology. 2011;26(10):1843- 1849. 4. Vieux R, Hascoet J-M, Merdariu D, Fresson J, Guillemin F. Glomerular filtration rate reference values in very preterm infants. Pediatrics. 2010;125(5):e1186-e1192. 5. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology. 2009;20(3):629-637. 6. Basalely A, Liu D, Kaskel FJ. Big equation for small kidneys: a newly proposed model to estimate neonatal GFR. Pediatric Nephrology. 2020. 7. Léger F, Bouissou F, Coulais Y, Tafani M, Chatelut E. Estimation of glomerular filtration rate in children. Pediatric nephrology. 2002;17(11):903-907. 8. Zhang Y, Mehta N, Muhari‐Stark E, Burckart GJ, Van Den Anker J, Wang J. Pediatric Renal Ontogeny and Applications in Drug Development. The Journal of Clinical Pharmacology. 2019;59:S9-S20. 9. Mould D, Upton R. Basic concepts in population modeling, simulation, and model‐based drug development. CPT: pharmacometrics & systems pharmacology. 2012;1(9):1-14. 10. Guignard J-P, Drukker A. Why do newborn infants have a high plasma creatinine? Pediatrics. 1999;103(4):e49-e49. 11. Allegaert K. Creatinine assays in early infancy: how to aim for a moving target. In: Patel V, Preedy V, eds. Biomarkers in Kidney Disease. Netherlands 2016:271-300. 12. Schreuder MF, Wilhelm AJ, Bökenkamp A, Timmermans SM, Delemarre-van de Waal HA, van Wijk JA. Impact of gestational age and birth weight on amikacin clearance on day 1 of life. Clinical Journal of the American Society of Nephrology. 2009;4(11):1774-1778. 13. Pacifici GM. Clinical pharmacokinetics of penicillins, cephalosporins and aminoglycosides in the neonate: a review. Pharmaceuticals. 2010;3(8):2568-2591. 14. Shaffer SG, Bradt SK, Hall RT. Postnatal changes in total body water and extracellular volume in the preterm infant with respiratory distress syndrome. The Journal of pediatrics. 1986;109(3):509- 514. 15. Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition: Kenneth D. Blackfan memorial lecture. Pediatrics. 1961;28(2):169-181. 16. Ahn Y. Formula and scale for body surface area estimation in high-risk infants. Collegium antropologicum. 2010;34(4):1273-1280. 17. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics. 1981;9(4):503-512. 18. Du Bois D, Du Bois EF. A Formula to Estimate the Approximate Surface Area if Height and Weight Be Known. . Archives of Internal Medicine,. 1916; 17:863-871. 19. Allegaert K, Kuppens M, Mekahli D, et al. Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method. The Journal of Maternal-Fetal & Neonatal Medicine. 2012;25(9):1678-1681.